Novartis and Molecular Partners report positive topline data from phase-II study for Ensovibep
The secondary endpoint of hospitalisation and/or ER visits related to COVID-19, or death showed an overall 78 per cent reduction…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.